In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oxford Nanopore Technologies Ltd.

Latest From Oxford Nanopore Technologies Ltd.

UK Orders 450K POC Tests For COVID-19, First Diagnostic From Oxford Nanopore

The LamPORE assay will also be used to test for the winter influenza virus.

United Kingdom Coronavirus COVID-19

UK Still Looking For The Magic Bullet To Reach COVID-19 Testing Goals

Viral testing of swabs using PCR to confirm COVID-19 in individuals continues to be the main thrust of the UK’s coronavirus control efforts as it targets 100,000 and more tests a day. PCR alternatives and antibody testing will come into the picture more in the coming weeks.

United Kingdom Coronavirus COVID-19

Woodford Woes Drag On For Immunocore

Once seen as the champion of biotech start-ups, Woodford’s blind faith has shackled firms to unrealistic valuations.

United Kingdom Companies

Woodford Debacle Is A Test Of UK Biotech’s Resilience

As once-star investment funds fail, another major investor argues this is opportunity for UK biotech to demonstrate staying power.

United Kingdom Financing
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • Oxford NanoLabs Ltd
    • STS Diagnostics.